Access to Medicine Foundation
The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Access to Medicine Index
Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.
Antimicrobial Resistance Benchmark
Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.
Access to Vaccines Index
Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Download the full research reports and methodologies from the Foundation's three research programmes, as well as studies, articles and briefing papers on how pharmaceutical companies address specific access-to-medicine priorities.
published on 29 Oct 2013
Learn more
published on 27 Nov 2012
published on 01 Oct 2012
published on 16 May 2012
published on 17 May 2011
published on 07 Jun 2010
published on 19 Jan 2010
published on 19 Nov 2008
published on 02 Jun 2008
Back to top |
